GPT and metabolic dysfunction-associated steatotic liver disease: Liver enzymes were assessed for detection of non-alcoholic fatty liver disease (NAFLD) including ALT (29.30 ± 27.60 U/L), AST (22.90 ± 17.50 U/L) and GGT (25.50 ± 17.40 U/L).